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Both metabolic and environmental risk factors are involved in the pathogenetic mechanisms 
of kidney stone formation. Major advances have been made in the concept of the 
pathogenesis, diagnosis, and treatment of kidney stone disease over the last decade. It 
remains a major health burden worldwide. It is considered a systemic disorder associated 
with chronic kidney disease, bone loss and fractures, increased risk of coronary artery 
disease, hypertension, type 2 diabetes mellitus, and the metabolic syndrome. Many 
therapeutic interventions which can effectively target the stones are available but these are 
associated with untoward effects. In the pursuit of finding better alternatives, large number of 
plants was screened for their antiurolithiatic activity. They were found to possess potent 
activity with minimal/no side effects. Development of new therapeutic agents is possible by 
understanding the link between nephrolithiasis and these systemic disorders. 
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INTRODUCTION 
Nephrology is the scientific study of the 
anatomy, physiology, and pathology of the 
kidneys. After the kidneys filter blood 
plasma, they return most of the water and 
solutes to the blood stream. Urine is made 
with remaining water and solutes. It passes 
through the ureters, stored temporarily in 
the urinary bladder and then excreted out 
through the urethra. The branch of 
medicine that deals with the male and 
female urinary system and the male 
reproductive system is urology. 
 
FUNCTIONS OF URINARY SYSTEM 
The kidneys perform wide range of 
functions which include regulation of 
composition and volume of blood, blood 
pressure, synthesis of glucose and vitamin-
D, release of erythropoietin and excrete 
wastes in the urine. 
 
Being the vital excretory organ, kidneys 
are susceptible to various pathogenic 
stimuli leading to marked reduction in 
their function. The following are some of 
the most common renal problems:  
LIST OF KIDNEY DISEASES 
 Acute kidney failure or acute kidney 
injury 
 Acute tubular necrosis 
 Anorexia nervosa and kidney disease 
 Congenital nephrotic syndrome 
 Diabetes and diabetic kidney disease 
 Diabetes insipidus 
 Glomerular disease  
 Good pasture syndrome 
 Kidney stone, nephrolithiasis 
 Lupus, systemic lupus erythematosus  
 Medullar cystic kidney disease 
 Metabolic acidosis 
 Myeloproliferative neoplasms and 
glomerulopathy 
 Nephrotic syndrome 
 Neurogenic bladder 
 Renal artery stenosis 
 Urinary tract infection 
 
Among the above mentioned renal 
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NEPHROLITHIASIS OR 
UROLITHIASIS 
Chemicals present in the urine usually 
results in the formation of kidney stone. 
Various wastes are present in the urine. 
Crystals begin to form when the amount of 
these wastes increases. Other elements 
deposit on these crystals to form a solid 
that will not get excreted if its size is 
larger. Kidneys usually eliminate these 
chemicals through the urine. Consumption 
of more liquid helps to remove the wastes 
and stops the formation of stones. The 
stone may stay either in kidney, urinary 
tract or ureter after its formation. If the 
stone size is small then it passes out 
without causing much pain. But stones that 
don't move may cause a backup of urine in 
the kidney, ureter, the bladder or the 
urethra. This is what causes the pain. 




There are four types of kidney stones 
which blocks and alters the kidney 




They are more common in urea. The 
average age of onset is the third decade, 
approximately 60% of people who form a 
single calcium stone eventually form 
another within the next 10years. The 
average rate of new stone formation in 
patients who have had a previous stone is 
about one stone every 2or3 years. Calcium 
stone disease is frequently familiar. In the 
urine, calcium oxalate monohydrate 
crystals (whewellite) usually grow as 
biconcave ovals that resemble red blood 
cells in shape and size but may occur in a 
larger, "dumbbell" form. In polarized light 
the crystals appear bright against dark 
background with an intensity that is 
dependent on orientation, property known 
as birefringence, Calcium oxalate 
dihydrate crystals (weddelite) are 
bipyramidal [4]. This condition appears to 
be hereditary and its diagnosis is straight 
forward. In some patients, primary 
intestinal hyper absorption of calcium 
causes transient postprandial 
hypercalcemia that suppresses secretion of 
parathyroid hormone. The renal tubules 
are deprived of the normal stimulus to 
reabsorb calcium at the same time that the 
filtered load of calcium is increased. In 
other patients, reabsorption of calcium by 
the renal tubules appear to be defective 
and secondary parathyroidism is evoked 
by urinary losses of calcium. Renal 
synthesis of 1, 2,5dihydroxyvit-D is 
increased, enhancing intestinal absorption 
of calcium [5]. In the past the separation of 
absorption and renal forms of hyper 
calciuria was used to guide treatment. 
Hypercalciuria contributes to stone 
formation by raising urine saturation with 
respect to calcium oxalate and calcium 
phosphate [6]. 
 
URIC ACID STONES 
They are radiolucent and are also more 
common in urea. Half of the patients with 
uric acid stones have gout. Uric acid 
lithiasis is usually familiar whether or not 
gout is present. In urine uric acid crystals 
are red-orange in colour because they 
absorb the pigment uricine. Anhydrous 
uric acid produces small crystals that 
appear amorphous by light microscopy. 
They are indistinguishable from apatite 
crystals, except for their birefringence. 
Uric acid dihydrate tends to form tear 
drop-shaped crystals as well as flat, 
rhomboid plates. Uric acid granules appear 
like red dust [7]. These are formed because 
the urine becomes supersaturated with 
undissociated uric acid that is protonated 
at its N-9 position. In gout, idiopathic 
lithiasis and dehydration, the average pH is 
usually below5.4 and often below5.0 
undissociated uric acid therefore 
predominates and is soluble in urine only 
in concentration of 100mg/L. 
Concentration above this level represents 
super saturation that causes crystals and 
stone formation. Uric acid crystals can 
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CYSTINE STONES 
These are uncommon, lemon yellow and 
sparkle. Radiopacity is due to the sulfur 
content; they are in flat, hexagonal shapes. 
In this, proximal tubular and jejunal 
transport of the dibasic amino acids 
cystine, lysine, argenine and ornithine are 
defective and excessive amounts are lost in 
the urine. Cystine is transported by a 
separate transport mechanism because 
cystinuria and dibasic amino aciduria can 
occur independently [8]. Three types of 
inheritance have been described. A gene 
located on chromosome 2 and designated 
SLC3A1, codes for a dibasic amino acids 
transporter and has to be formed to be 
abnormal in type1 cystinuria. Linkage 




These are common and potentially 
dangerous. These stones occur mainly in 
women or patients who require chronic 
bladder catheterization and result from 
urinary tract infection with urease 
producing bacteria, usually proteus 
species. The stones can grow to larger size 
and fill the renal pelvis and calyces to 
produce a "staghorn" appearance. They are 
radiopaque and have a variable internal 
density. In urine, Struvite crystals are 
“rectangular prisms” said to resemble 
coffin lids [9]. 
 
 
Figure 1: Types of stones 
 
PREVALENCE  
The prevalence of urolithiasis is 
approximately 2-3% in the general 
population, and the estimated life time risk 
of developing a kidney stone is about 10% 
for white males. Approximately 50% of 
patients with previous urinary calculi have 
a recurrences within 10years. Stone 
disease is 2-3times more common in males 
than in females [10]. It occurs more often 
in elderly persons of Asians ethnicity, who 
is affected more often than blacks.  
 
CAUSES OF KIDNEY STONES 
The risk of developing kidney stones could 
increase by calcium and vitamin-D 
supplements because they elevate calcium 
levels in the blood and urine. Chemically 
kidney stones are calcium oxalate, formed 
due to the precipitation of dissolved 
minerals on the inner lining of kidneys. 
These deposits can grow to the size of a 
golf ball while maintaining a sharp, 
crystalline structure [11]. 
 
Lack of water is the important cause of 
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been found in these that drink less than the 
recommended eight to ten glasses of water 
a day. The pH level in the kidneys 
decreases and becomes more acidic when 
there is inadequate water to dilute the uric 
acid. An excessively acidic environment in 
the kidneys is conductive to the formation 
of kidney stones. Medical conditions such 
as crohn's disease, urinary tract infections 
renal tubular acidosis, hyper parathyroid, 
medullary sponge kidney, and dent's 
disease have been known to lead to kidney 
stones. Addition of fluoride to drinking 
water (fluoridation) has been suggested to 
be responsible for some cases of kidney 
stones. Magnesium ammonium phosphate 
stones are formed largely after infections 
by urea splitting bacteria (ex: proteus and 
some staphylococci) which convert urea to 
ammonia. Magnesium ammonium 
phosphate salts precipitate due to the 
alkalization of urine. 
 
More than half of all patients with urate 
calculi have neither hyperuricemia nor 
increased urinary excretion of uric acid 
[12]. 
 
COMPLICATIONS OF KIDNEY 
STONES 
If a kidney stone is blocking your ureters, 
you may develop a severe infection, which 
can become life threatening without 
treatment. Signs of an infection include 
having a fever and cloudy urine [13]. It's 
essential to take treatment in the presence 
of these symptoms. People suffering with 
recurring kidney stones are thought to 
have   
 A 20% chance of having another 
within 5 years. 
 A 35% chance of having another 
within 10 years. 
 A 75% chance of having another 
within 20 years. 
 
The best way to help prevent recuring 
kidney stone is to drink plenty of water 
every day to avoid dehydration.   
 
SYMPTOMS OF THE KIDNEY 
STONES 
A kidney stone usually remains 
symptomless until it moves into the ureter. 
When symptoms of kidney stone become 
apparent, they commonly include. 
 Severe pain in the groin and/or side 
 Blood in urine 
 Vomiting and nausea, feeling sick 
 WBC or pus in the urine 
 Reduced amount of excreted urine 
 Burning sensation during urination 
 Persistent urge to urinate 
 Fever and chills if there is an infection 
 Sudden spasms excruciating pain these 
usually starts in your back below your 
ribs and move down and around to the 
front of your abdomen(tummy) 
 The pain may wake up you when you 
are asleep and, may last between three 
and 18hours. [13]. 
 
MECHANISM OF RENAL STONE 
FORMATION 
Urinary supersaturation and formation of 
crystalline particles lead to the 
development of renal stones. Super 
saturation is the driving force for 
crystallization in solution like urine [14]. 
Until a particular concentration, the salt or 
solute gets dissolve in the solvent after 
which no further dissolution is possible. 
Then the solvent is said to be saturated 
with the salt. The salt gets crystallizes out 
if added more in the constant temperature 
and pH. The concentration at which this 
crystallization begins is termed as 
thermodynamic solubility product (Ksp). It 
finally results in nephrolithiasis if 
inhibitors were not able to act. These 
inhibitors permit to hold higher amount of 
calcium in solution rather than pure 
solvent. Urine is metastable with respect to 
calcium salts. Indeed, stone formers tend 
to excrete that is more supersaturated than 
that of non stone formers [15]. It has been 
suggested that with a transit time across 
kidney of 5-10 min, residence time is too 
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Conversion from a liquid to a solid phase 
in a supersaturated solution is termed 
nucleation which is the first step involved 
in kidney stone formation. It starts by the 
binding of salts in solution to form loose 
clusters which increase in size by addition 
of new clusters [16]. 
 
The first crystals formed from the nuclei 
do not dissolve and possess a characteristic 
lattice pattern. This process of formation 
of crystals from nuclei is called as 
heterogenous nucleation. In urine, 
epithelial cells, urinary casts, RBCs and 
other crystals act as nucleating centers. 
The saturation necessary for this 
heterogenous nucleation is much less than 
that of homogenous nucleation [17]. Once 
the anchoring of the generated nucleus 
occurs, crystallization process proceeds at 
relatively lower chemical pressure than 
required for the formation of initial 
nucleus. Renal tubular cell injury can 
promote crystallization of CaOX crystals 
by providing substances for their 
heterogenous nucleation. In-vitro cell 
degeneration following renal tubular cell 
injury produces numerous membrane 
vesicles, which have been shown to be 
good nucleators of calcium crystals. In 
vitro crystals observed in the renal tubules 
of hyperoxaluric rats are always associated 
with cell degeneration products. 
 
CRYSTAL GROWTH 
Once a crystal nucleus has achieved a 
critical size and relative super saturation 
remains above one the overall free energy 
is decreased by adding new crystal 
components to the nucleus, this process is 
called the crystal growth. Crystal growth is 
one of the prerequisite for particle 
formation and thus for stone formation, 
crystal growth and aggregation have 
important functions. Honda et al reported 
that the crystal surface binding substances 
which is found in CaOX crystals generated 
from whole human urine is strong 
inhibitors of CaOX crystal growth and 
contains proteins like human serum 
albumin, retinol binding protein, 
transferring, Tamm-horsfall glycoprotein 
and prothrombin [18]. The importance of 
crystal growth for the most abundant stone 
ie., CaOX is questionable. The probability 
of single particle is extremely low because 
the rate of CaOX crystal growth is low and 
transit time of tubular fluid through the 
kidney is several minutes [19]. Achieving 
pathophysiologic ally relevant size by the 
process of crystal growth alone is 
extremely low, even if growth proceeds at 
an uninhabited rate of 2mm per minute. 
Based on the quantity normally excreted, 
the inhibitory effect of fibronectin (FN) on 
the growth of CaOX crystals is small.  
 
CRYSTAL AGGREGATION 
Aggregation is the process of binding of 
crystals in solution to form larger particles. 
It is the most important step in stone 
formation according to some researchers. 
The process of crystal growth is very slow 
that it cannot become large enough to 
obstruct the renal tubules and retained 
there by this mechanism alone. Hence the 
crystal aggregation is considered to be the 
critical step in stone formation [20]. 
According to all models of CaOX 
urolithiasis, crystal aggregation is probably 
involved in the retention of crystals in the 
kidney. It has a prominent effect on 
particle size and aggregated crystal are 
commonly found in urine and renal stones. 
Viscous binding promotes crystal 
aggregation indicating that foreign 
compounds with multiple binding sites 
such as Tamm-Horsfall glycoprotein 
attach to crystal surface and act as kind of 
glue [21]. 
 
CRYSTAL CELL INTERACTION 
The mechanism of crystal cell interaction 
is thought to be very complex, and many 
of them remain unexplored. Crystallization 
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saturation. Then, the crystals that have 
formed attach to renal tubular epithelial 
cells and are taken into them. The process 
of attachment or endocytosis of crystals to 
renal tubular cells, what is generally meant 
by crystal cell interaction these structural 
and functional studies of crystal cell 
interaction in culture indicate that calcium 
oxalate monohydrate (COM) crystals 
rapidly adhere to microvilli or the cell of 
surface and are subsequently internalizes 
[22]. Khan et al. concluded that urinary 
stone disease develops due to interaction 
of crystal cells. It is thought to be the first 
process in the formation of kidney stones. 
According to Finlayson and Reid 
hypothesis, it was unlikely to block renal 
tubules by the growth of CaOX crystals, 
and that attachment of crystals was 
necessary for initiation of stone formation. 
There have been many reports on crystal 
attachment. Animal model and tissue 
culture studies have provided evidence for 
crystal retention within the kidneys via 
attachment to renal epithelial cells crystal 
attachment to the brush border of proximal 
tubules in rats. Experimental introduction 
of CaOX urolithiasis starts with 
hyperoxaluria followed by crystalluria and 
deposition in the kidney. Some urinary 
macromolecules have an inhibitory effect 
on CaOX crystal attachment. Diverse 
polyanionic molecules in urine, such as 
specific glycosaminoglycans, glycol 
proteins, and citrate, block the binding of 
COM crystal to the cell membrane [23]. 
One common feature of molecules that 
inhibit COM crystals and adhesion to cells 
is their polyionic character. They 
mentioned that although polyanions 
present in tubular fluids may coat crystals 
and thereby inhibit their adhesion to 
tubular cells, a distinct and separate set of 
signals act on the cells to regulate their 
response to crystals that to bind. 
 
DIAGNOSIS AND INITIAL 
MANAGEMENT OF KIDNEYS 
Urolithiasis is a challenging problem to 
clinicians since the time of Hippocrates 
and many physicians have good 
experience in its management. Technical 
advancements in recent years have 
facilitated the proper diagnosis of this 
disease. There is a gradual development in 
the management of urolithiasis. Clear 
indications for urologic refferralare based 
on recognition of the few urgent situations 
and a solid understanding of the natural 
history of stone progression [24].
 





Specificity (%) Advantages Limitations 
Ultrasonography 19 97 
Accessible require no 
ionizing radiation 







Stones in middle section 
of ureter, phleboliths, 






information on  
anatomy and 
functioning of both 
kidneys 
Variable quality imaging 
requires bowel preparation 
delayed images require in 







Most sensitive and 
specific radiologic test. 
An indirect sign of the 
degree of obstruction 
provides information on 
non genitourinary 
conditions. 
Less accessible and 
relatively expensive no 
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PRESENTATION AND 
DIFFERENTIAL DIAGNOSIS 
Urolithiasis should always be considered 
in the differential diagnosis of abdominal 
pain. The pain of renal colic often begins 
as vague flank pain. Patients frequently 
dismiss this pain until it evolves into 
waves of severe pain. It is believed that a 
stone must at least partially obstruct the 
ureter to cause pain. The pain is commonly 
referred to the lower abdomen and to the 
ipsilateral grain [25]. As the stone 
progresses down the ureter, the pain tends 
to migrate caudally and medially. 
 
STONE LOCATION COMMON SYMPTOMS 
Kidney vague flank pain, hematuria 
Proximal ureter                         renal colic, flank pain, upper abdominal pain 
 
Middle section of ureter renal coli, anterior abdominal pain, flank pain 
Distal ureter  renal colic dysuria, urinary frequency, anterior 
Abdominal pain, flank pain 
 
 
               
Urine analysis should be performed in all 
patients with suspected calculi. A side 
from the typical microhematuria, 
important findings to note is the urine pH 
and the presence of crystals, which may 
help to identify the stone composition [26]. 
Patients with uric acid stones usually 
present with acidic urine and those with 
stone formation resulting from infection 
have alkaline urine 
 
Identification of bacteria is important in 
planning therapy and a urine culture 
should be routinely performed [27]. 
Limited pyuria is a fairly common 
response to irritation caused by a stone and 
in absence of bacteruria is not generally 
indicative of coexistent urinary tract 
infection [28, 29]. Urinary calculi can also 
be detected by modern imaging studies 
which provides exact location and severity 
of the situation (Table 1). 
 
KIDNEY STONES MEDICATIONS 
MEDICINE TO HELP PASS STONES 
Non-steroidal anti-inflammatory drugs 
(NSAIDs) may relieve pain while passing 
a stone [30]. Doctors may also prescribe 
medicine to pass the stone such as alpha-
blocker 
 
MEDICINES TO PREVENT STONES 
Calcium stones: most common stones. 
 Orthophosphate 
 Potassium citrate 
 Thiazides 
Uric acid stones 
 Allopurinal 
 Potassium citrate 








 Urease inhibitors 
 Antibiotic to cure the infection [31, 32]  
  
Medical management of patients with 
urolithiasis is crucially important for their 
outcome. The principle goals of medical 
efforts are manifold as listed below. 
 Relief pain during renal colic. 
 From spontaneous expulsion of 
ureteral stones 
 Prevent formation or growth of renal 
stones 
 Reduce the need of urologic 
procedures 
 Reduce the occurrence of complicating 
events such as infection and/or 
obstruction 
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 Avoid onset and progression of renal 
insufficiency 
 
Alternative or complimentary medicine 
Now-a-days, however, herbal medicine 
has gained much popularity because, 
herbal medicines are more effective, have 
less side effects, and reduce recurrence 
rate of stone formation. Hence search for 
antilithiatic drug from natural sources has 
assumed greater importance and 
promising. Herbal medicines have many 
phytoconstituents which may exert their 
beneficial effect in kidney stone treatment. 
Many plants were screened for their 
antilithiatic activity and proved to be 
potent.   
 
SURGERY FOR KIDNEY STONES: 
Surgery may be needed to remove a 
kidney stone if it 
 Causes pain without passing out even 
after a reasonable period of time.  
 Caught in a different place because of 
its large size. 
 Urine flow is blocked. 
 Urinary tract infections are resulted. 
 Damages kidney tissue or causes 
constant bleeding. 
 Stones are seen in X-ray if grown 
larger. 
 
Open surgery was necessary to remove a 
stone up to 20 years back. The surgery 
required a recovery time of 4 to 6 weeks 
[33]. Many options do not require major 
open surgery and can be performed in an 
outpatients setting. 
 
COMPLICATIONS OF TREATMENT 
The different kinds of treatment for larger 
stones may cause some complications. The 
surgeon should explain these procedures. 
Possible complications will depend on 
type of treatment, the size and position of 
stones.  
Complications could include. 
 Sepsis- an infection that spreads 
through the blood, causing symptoms 
throughout its whole body. 
 Steinstrasse- this is the medical name 
for a blockage caused by fragments of 
stone in the ureter. 
 An injury to the ureter. 
 Urinary tract infection. 
 Bleeding during surgery. 
 Pain. 
 It is estimated that 5-9% of people may 
experience Complications after having 
Uretrorenoscopy [34].  
 
PREVENTION 
Rather than having to undergo treatment, it 
is best to avoid kidney stone in the first 
place when possible. It can be especially 
helpful to drink more water, since low 
fluid intake and dehydration are major rule 
factors for kidney stone formation [35]. 
 
People who have a tendency to form 
calcium oxalate kidney stones may be 
advised to limit their consumption of 
blood high in oxalate, such as spinach 
rhubarb, Swiss chord, beat, wheat grains 
and peanuts. Also drinking lemon juices or 
lemonade may be helpful to prevent 
kidney stones [36]. 
 
Over the counter pain medicines 
ibuprofen, naproxen either alone or along 
with narcotics can be very effective. 
 
CONCLUSION 
Nephrolithiasis, a systemic disorder that 
may progress into end-stage renal disease. 
Hence the term stone former is used. It is a 
pandemic disorder with increasing 
incidence as that of diabetes mellitus, 
metabolic syndrome and the aging 
population. The pathogenesis of 
nephrolithiasis is a complex mechanism 
that is not fully explored suggesting that 
kidney stones are phenotype of a 
syndrome in which genetic, environmental 
and metabolic factors each contribute to a 
different extent. Understanding the 
pathophysiological pathways of 
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nephrolithiasis as part of this syndrome 
rather than as an isolated disease. 
Although many theories have been 
proposed and much research has been 
carried out, further investigation in this 
field is required.  
DECLARATION OF INTEREST 
The authors report no conflicts of interest. 
The authors alone are responsible for the 
content and writing of the paper. 
 
REFERENCE 




2. Sakhaee K, Maalouf NM, Kumar R, 
Pasch A, Moe OW. Nephrolithiasis-
associated bone disease: pathogenesis 
and treatment options. Kidney Int. 
2011; 79: 393-403p. 
3. Rodman JS. Struvite stones. Nephron 
1999; 81(1):50p. 
4. Harrison. Principles of internal 
medicine. McGraw-Hill, New Delhi, 
volume 2001; 2(15): 1615p. 
5. KokDJandKhanSR.“Calcium oxalate 
Nephrolithiasis, a free or fixed particle 
disease” Kidney Int.1994; 46 (3): 847-
854p. 
6. Curhan GC et al. Comparison of 
dietary calcium with supplemental 
calcium and other nutrients as factors 
affecting the risk of kidney stones in 
women. Ann Intern Med. 1997; 
126:497p. 
7. Segura JW et al. Ureteral Stones 
Clinical Guidelines Panel summery 
report on the management of ureteral 
calculi. J Urol. 1997; 158:1915p. 
8. Bruno M, Marangella M. Cystinuria: 
recent advances in pathophysiology 
and genetics. Contribnephrol. 1997; 
122:173p. 
9. AggarwalS, TandonCD, 
ForouzandehM, SinglaSK, KiranR, 
and JethiRK.“Role of biomolecules 
from human renal stone matrix on 
COM crystal growth.” Molecular and 
cellular biochemistry. 2000; 210 (1-2): 
109-119p. 
10. Romero V, Akpinar H, Assimos DG. 
Kideny stones: a global picture of 
prevalence, incidence, and associated 
risk factors. Rev Urol. 2010; 12: e86- 
e96p. 
11. Williams HE. Nephrolithiasis. N Engl 
J Med. 1974; 33: 290p. 
12. Borghi L et al. Urinaryvolume, water 
and recurrences in idiopathic calcium 
nephrolithiasis: A 5 year randomized 
prospective study. J Urol. 1996; 
155:839p. 
13. Coe FL, Parks JH. New insights into 
the pathophysiology of and treatment 
of nephrolithiasis: new research 
venues. J Bone Miner Res. 1997; 
12:522p. 
14. VermevlenC, WandlonES.“Mechanism 
of genesis and growth of calculi” The 
American Journal of Medicine. 1956; 
45(5): 684-691p. 
15. Mandel NS, Mandel GS. Urinary tract 
stone disease in the United States 
veteran population. II. Geographical 
analysis of variations in composition. J 
Urol. 1989; 142: 1516-1521p. 
16. Christos Paliouras, EiriniTsampikaki, 
PolichronisAlivanis, GeorgiosAperis.  
Pathophysiology of nephrolirhiasis. 
Nephrology Reviews. 2012; 4(14): 58-
65p. 
17.  Mandel N.  Mechanism of stone 
formation. SeminNephrol.1996; 16: 
364-74p. 
18. Morse RM and ResnickMI. ”A new 
approach to the study of urinary 
macromolecules as a participant in 
calcium oxalate crystallization” The 
journal of Urology. 1988; 139 (4): 869-
873p. 
19. RoyallRL, HarnetRL, HibberdCM, 
EdyeaneKA, Marshall VR. “Effects of 
chondroitin sulphate, human serum 
albumin and Tamm-
Horsfallmucoprotein on calcium 
oxalate crysstallization in undiluted 
human urine”. Urological Research. 
1991; 19(3): 181-188p. 




26 Page 17-26 © MAT Journals 2019. All Rights Reserved 
 
Journal of Pharmacological Research and Developments 
Volume 1 Issue 1 
“Presence of lipids in urinary stones: 
results of preliminary studies” 
Calsified Tissue International. 1988; 
42(2): 91-96p. 
21. Coe FL, Evan AP, Worcester EM, 
Lingeman JE. Three pathways for 
human kidney stone formation. Urol 
Res. 2010; 38: 147-60p. 
22.  Thomas Knoll. Epidemilogy, 
pathogenesis, and pathophysiology of 
urolithiasis. European Urology 
Supplements. 2010; 9: 802-806p. 
23.  Evan AP, Lingeman JE, Coe FL, Shao 
Y, Parks JH, Bledsoe SB, Phillips CL, 
Bonsib S, Worcester EM, Sommer AJ, 
Kim SC, Tinmouth WW, Grynpas M. 
Crystal-associated nephropathy in 
patients with brushite.Nephrolirhiasis. 
2005; 67: 576-591p. 
24. KhashayarSakhaee, NaimMaalouf M, 
Bridget Sinnott. Kidney stones: 
Pathogenesis, diagnosis, and 
management. J ClinEndocrinolMetab. 
2012; 97(6): 1847-1860p. 
25. Asplin JR, Parks JH, Coe FL. 
Dependence of upper limit of 
metastability on supersaturation in 
nephrolirhiasis. Kidney Int. 1997; 52: 
1602-8p. 
26. Evan AP. Pathophysiology and 
etiology of stone formation in the 
kidney and the urinary tract. 
PediatrNephrol. 2010; 25: 831-41p. 
27. CarvahloM, NakagawaY. “Urinary 
supersaturation and recurrence in 
nephrolithiasis”. International 
Brazilian Journal of Urology. 1999; 
25: 475-479p. 
28. LieskeJC, DeanelloS, 
TobackFG.“Cell-crystal interactions 
and kidney stone formation”. Nephron. 
1999; 81(1): 8-17p. 
29. Kramer G et al. Role of bacteria in the 
development of kidney stones. 
CurrOpinUrol. 2000; 10:35p. 
30. Orson Moe W. Kidney stones: 
Pathophysiology and medical 
management. The Lancet. 2006; 
367(9507): 333-344p. 
31. Consensus Conference. Prevention and 
treatment of kidney stones. JAMA. 
1988; 260:977p. 
32.  Charlotte Dawson H, Charles Tomson 
RV.Clinical Medicine. 2012; 12(5): 
467-71p. 
33.  Pearle MS, Roehrborn CG, Pak CY. 
Meta-analysis of randomized trial for 
medical prevention of calcium oxalate 
nephrolirhiasis. J Endourol. 1999; 13: 
679-85p. 
34. Yendt ER, Cohanim M. Prevention of 
calcium stones with thiazides. Kidney 
Int. 1978; 13: 397p. 
35. Heilberg IP. Update on dietary 
recommendation and medical 
treatment of renal stone disease. 
Nephrol Dial Transplant. 2000; 
15:117p. 
36. Borghi L, Meschi T, Amato F et al. 
Urinary volume, water and recurrences 
in idiopathic calcium nephrolirhiasis: a 
5-year randomized prospective study. J 
Urol.1996; 155: 839-43p. 
 
Cite this article as: 
Bhukya Balaji, Dr. C.V.S. 
Subrahmanyam, & Dr. P. Veeresh 
Babu. (2019). Nephrolithiasis – Most 
Debilitating Renal Disorder. Journal of 
Pharmacological Research and 
Developments, 1(1), 17–26. 
http://doi.org/10.5281/zenodo.2605000 
 
